# Revier Therapeutics funding rounds and investors

As of 14 Oct 2026, Revier Therapeutics has raised $7.0M across 1 verified round on record (amounts in other currencies converted to USD); latest: €6 million seed round led by KHAN Technology Transfer Fund II, announced 25 Aug 2026.

A biotech company

Website: https://www.revier.bio  
Headquarters: Heidelberg  
Page: https://fireround.dev/companies/revier-therapeutics

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-08-25 | Seed | €6 million | KHAN Technology Transfer Fund II | High-Tech Gründerfonds (HTGF), Revier Invest Heidelberg, VORNvc | [revier.bio](https://revier.bio/revier-therapeutics-launches-6-million-seed-financing), [globenewswire.com](https://www.globenewswire.com/news-release/2026/08/25/3350246/0/en/revier-therapeutics-launches-with-6-million-seed-financing-to-pioneer-class-iia-hdac-inhibitors-for-cardiometabolic-disease.html), [eu-startups.com](https://www.eu-startups.com/2026/08/heidelberg-based-revier-therapeutics-launches-with-e6-million-to-develop-cardiometabolic-therapies) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.